Miscellaneous

Invited Discussant 3PD, 51PD and 132PD

Authors
  • Federico Cappuzzo (IT)
Presenter
  • Federico Cappuzzo (IT)

Previous ePoster
106P - The value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma

Next ePosters
20P - ArgSS1 expression in squamous cell carcinoma of the lung
96P - The role of bronchial stump reinforcement by flap in prevention of broncho-pleural fistula after major lung resections
219P - Outcomes of malignant pleural mesothelioma (MPM) patients (p) treated after first line chemotherapy (CT)
11P - Glycolysis enzyme screenings identify non-glycolytic function of aldolase A that interacts and alters F-actin dynamics to promote lung cancer metastasis
34P - Recommendations for EGFR mutation testing with a fast and fully automated sample-to-result system: How to optimize DNA input instead of using lung cancer tissue?
160P - Real world study of lung squamous cell carcinoma patients with EGFR mutation treated with EGFR-TKI
185P - Retrospective study of tumour responses and toxicities associated with anti-PD1 antibody therapy in elderly cancer patients(>75yo) in comparison to patients ≤75yo with metastatic non-small cell lung cancer
14P - MMP-2 1306 C/T promoter polymorphism and smoking: A possible role as risk factors in lung cancer
124P - Cardiac events in stage III non-small cell lung cancer (NSCLC): An attention shift to cardio-oncology collaboration
152P - Impaired liver function was associated with PFS of EGFR TKI treatment